Zurich Cantonal Bank
RYTM icon

Zurich Cantonal Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Zurich Cantonal Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,435
Closed -$1.33M – 3350
2025
Q4 		$1.33M Buy
+12,435
New +$1.32M ﹤0.01% 1183

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Zurich Cantonal Bank's RYTM Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Rhythm Pharmaceuticals (RYTM) in Q1 2026: 15,598 shares worth $1.36M. The stake represents ﹤0.01% of the portfolio and ranks #1255 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in RYTM as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in RYTM in Q4 2019 and has held it in 25 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Zurich Cantonal Bank held 15,598 shares of Rhythm Pharmaceuticals worth $1.36M as of Q1 2026.
  • Rhythm Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1255 holding.
  • Zurich Cantonal Bank first reported a position in Rhythm Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.